Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Waters

Showing results (181-190 of 198) with videos related to

Pageof 20
Sort By:
Nature Genetics|August 13, 2013
GRIN2A mutations in acquired epileptic aphasia and related childhood focal epilepsies and encephalopathies with speech and language dysfunctionGaetan Lesca, Gabrielle Rudolf, Nadine Bruneau, et al.
Plos One|March 9, 2018
Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical featuresKee Hong Park, Patrick Waters, Mark Woodhall, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 16, 2021
Differential Binding of Autoantibodies to MOG Isoforms in Inflammatory Demyelinating DiseasesKathrin Schanda, Patrick Peschl, Magdalena Lerch, et al.
The Lancet. Neurology|February 25, 2016
A clinical approach to diagnosis of autoimmune encephalitisFrancesc Graus, Maarten J Titulaer, Ramani Balu, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 29, 2021
Myelin Oligodendrocyte Glycoprotein-Immunoglobulin G in the CSF: Clinical Implication of Testing and Association With DisabilityYoung Nam Kwon, Boram Kim, Jun-Soon Kim, et al.
Brain : a Journal of Neurology|June 9, 2022
Cervical lymph nodes and ovarian teratomas as germinal centres in NMDA receptor-antibody encephalitisAdam Al-Diwani, Jakob Theorell, Valentina Damato, et al.
Multiple Sclerosis and Related Disorders|February 26, 2022
Response to treatment in NMOSD: the Australasian experienceLaura Clarke, Wajih Bukhari, Cullen M O'Gorman, et al.
Annals of Neurology|July 3, 2023
Do Early Relapses Predict the Risk of Long-Term Relapsing Disease in an Adult and Paediatric Cohort with MOGAD?Bo Chen, Enrique Gomez-Figueroa, Vyanka Redenbaugh, et al.
JAMA Neurology|September 3, 2024
Time to Treat First Acute Attack of Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseYoung Nam Kwon, Boram Kim, Jun-Soon Kim, et al.
The Lancet. Neurology|August 21, 2021
Myelin-oligodendrocyte glycoprotein antibody-associated diseaseRomain Marignier, Yael Hacohen, Alvaro Cobo-Calvo, et al.
Pageof 20

Showing results (181-190 of 198) with videos related to

Sort By:
Pageof 20
Nature Genetics|August 13, 2013
GRIN2A mutations in acquired epileptic aphasia and related childhood focal epilepsies and encephalopathies with speech and language dysfunctionGaetan Lesca, Gabrielle Rudolf, Nadine Bruneau, et al.
Plos One|March 9, 2018
Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical featuresKee Hong Park, Patrick Waters, Mark Woodhall, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 16, 2021
Differential Binding of Autoantibodies to MOG Isoforms in Inflammatory Demyelinating DiseasesKathrin Schanda, Patrick Peschl, Magdalena Lerch, et al.
The Lancet. Neurology|February 25, 2016
A clinical approach to diagnosis of autoimmune encephalitisFrancesc Graus, Maarten J Titulaer, Ramani Balu, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 29, 2021
Myelin Oligodendrocyte Glycoprotein-Immunoglobulin G in the CSF: Clinical Implication of Testing and Association With DisabilityYoung Nam Kwon, Boram Kim, Jun-Soon Kim, et al.
Brain : a Journal of Neurology|June 9, 2022
Cervical lymph nodes and ovarian teratomas as germinal centres in NMDA receptor-antibody encephalitisAdam Al-Diwani, Jakob Theorell, Valentina Damato, et al.
Multiple Sclerosis and Related Disorders|February 26, 2022
Response to treatment in NMOSD: the Australasian experienceLaura Clarke, Wajih Bukhari, Cullen M O'Gorman, et al.
Annals of Neurology|July 3, 2023
Do Early Relapses Predict the Risk of Long-Term Relapsing Disease in an Adult and Paediatric Cohort with MOGAD?Bo Chen, Enrique Gomez-Figueroa, Vyanka Redenbaugh, et al.
JAMA Neurology|September 3, 2024
Time to Treat First Acute Attack of Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseYoung Nam Kwon, Boram Kim, Jun-Soon Kim, et al.
The Lancet. Neurology|August 21, 2021
Myelin-oligodendrocyte glycoprotein antibody-associated diseaseRomain Marignier, Yael Hacohen, Alvaro Cobo-Calvo, et al.
Pageof 20